Clinical trial NCT04992741: Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision
Official title: The Effect of Health belıef Model Based educatıon and motıvatıonal intervıewıng on Mothers' Knowledge, belıef and attıtudes Towards Hpv vaccıne
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: HPV VACCINATION
Keywords: HPV, Health Belief Model, Motivational Interview, Nursing
Lead sponsor: University of Gaziantep
Sponsor class: OTHER
First posted: 2021-08-05
Enrollment: 63
Sex: FEMALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: This research is a single-blind, randomized, parallel-controlled experimental study designed to determine the effect of Health Belief Model (SIM)-based motivational interviews given to mothers of high school students on mothers' knowledge, beliefs and attitudes towards HPV vaccine. . The hypotheses of the research; The experimental group that received training and motivational interviews within the framework of SIM had higher knowledge and perception of HPV infection and vaccination in the posttest than the control group that did not receive any application.

Detailed description: Methods: In order to determine the sample size of the study, it was planned to work with a total of 54 patients, at least 27 patients in each group, in the power analysis performed by taking the reference information of the statistician and previous studies, and the study was completed with a total of 63 people (31 in the experimental group, 32 in the control group). The Health Belief Model-based motivational interview will be conducted over the phone and will last 15-20 minutes. One week after each motivational interview, a questionnaire and scale form will be applied to the mothers. After the third meeting, the study will be completed by applying the questionnaire and scale forms. Finally, the questionnaire for measurement will be filled and the research will be completed.

The control group will be subjected to routine processing without any intervention. Questionnaire forms were applied to the control group simultaneously with the experimental group. At the end of the study, a single-session motivational interview will be held by the researcher, since the patients in the control group have equal ethical rights. The primary result expected from the study is that mothers' perceptions of the benefit, sensitivity and severity of HPV vaccine increase, and their perception of barriers decreases. The secondary result expected from the study is the increase in mothers' knowledge about HPV infection and vaccination. The tertiary expected outcome of the study is that the mother sees her daughter at risk of HPV infection and decides to have her daughter vaccinated against HPV.

Eligibility criteria: Inclusion Criteria:

1. Those who live in Mersin and are female students in two high schools determined between 15.03.2020 and 15.06.2021.,
2. Daughter not vaccinated against HPV,
3. Undecided about getting her daughter vaccinated against HPV,
4. Who doesn't plan to have their daughter vaccinated against HPV,
5. who agreed to participate in the research,
6. Literate,
7. Can speak Turkish,,
8. Having no hearing or sight impairment that will prevent communication,,
9. Able to talk on the phone and use whatsapp,,
10. Participants without a diagnosed psychiatric problem were included in the study..

Exclusion Criteria:

1. Having her daughter vaccinated against HPV,
2. Thinking of getting her daughter vaccinated against HPV,
3. Who refused to participate in the research,
4. Illiterate,
5. Don't speak Turkish,
6. People with hearing or sight impairments that may interfere with communication,
7. Can't talk on the phone and can't use whatsapp,
8. Participants with diagnosed psychiatric problems were excluded from the study.

Primary outcomes:
measure: Primary Outcome Measures: Health Belief was assessed with the Health Belief Model Scale for Human Papilloma Virus Infection and Vaccination
timeFrame: Change from before implementation, 1th week, 2th week and 3th week of practice
measure: HPV information assessed with HPV information scale
timeFrame: Change from before implementation, Change from before implementation, 1th week, 2th week and 3th week of practice
Secondary outcomes:
Other outcomes:
Locations:
city: Mersin
country: Turkey
facility: Mersin University
Study officials:
affiliation: Turkey, Mersin University, Mersin, Yenişehir, Turkey, 33343
name: Yasemin Ateşeyan
role: STUDY_CHAIR
References: